PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
39.32
+0.88 (2.29%)
Oct 22, 2024, 4:00 PM EDT - Market closed
PTC Therapeutics Market Cap
PTC Therapeutics has a market cap or net worth of $3.02 billion as of October 23, 2024. Its market cap has increased by 85.85% in one year.
Market Cap
3.02B
Enterprise Value
4.41B
1-Year Change
85.85%
Ranking
Category
Stock Price
$39.32
Market Cap Chart
Since June 20, 2013, PTC Therapeutics's market cap has increased from $366.20M to $3.02B, an increase of 725.96%. That is a compound annual growth rate of 20.45%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 21, 2024 | 2.96B | 42.18% |
Dec 29, 2023 | 2.08B | -24.20% |
Dec 30, 2022 | 2.74B | -2.56% |
Dec 31, 2021 | 2.82B | -32.38% |
Dec 31, 2020 | 4.16B | 40.68% |
Dec 31, 2019 | 2.96B | 70.95% |
Dec 31, 2018 | 1.73B | 150.23% |
Dec 29, 2017 | 692.00M | 84.83% |
Dec 30, 2016 | 374.40M | -66.28% |
Dec 31, 2015 | 1.11B | -36.17% |
Dec 31, 2014 | 1.74B | 311.45% |
Dec 31, 2013 | 422.80M | 15.46% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Neogen | 3.09B |
Apogee Therapeutics | 3.06B |
Bausch Health Companies | 3.00B |
Iovance Biotherapeutics | 2.99B |
Astrana Health | 2.94B |
Kymera Therapeutics | 2.93B |
LivaNova | 2.89B |
Verona Pharma | 2.79B |